Table 2.

Clinical outcomes.

Variable	CKD* group (n = 85)			Non-CKD group (n = 106)
	FDI† group (n = 53)	Non-FDI group (n = 32)	P value	FDI group (n = 74)	Non-FDI group (n = 32)	P value
POD‡0 Hb§ (mg/dL)	10.98 ± 1.27	10.66 ± 1.33	.28	11.82 ± 1.23	11.88 ± 1.27	.80
POD 1 Hb (mg/dL)	10.12 ± 1.26	10.04 ± 1.41	.78	10.52 ± 1.26	10.63 ± 1.17	.68
POD 2 Hb (mg/dL)	8.93 ± 1.09	8.66 ± 1.25	.29	9.26 ± 1.45	9.28 ± 1.29	.93
POD 7 Hb (mg/dL)	9.09 ± 1.20	9.08 ± 1.18	.93	9.40 ± 1.24	9.40 ± 1.20	.99
POD 14 Hb (mg/dL)	10.08 ± 1.01	10.02 ± 1.07	.79	10.70 ± 0.99	10.64 ± 1.03	.79
Transfusion rate	16 (30.2%)	18 (56.3%)	.02	17 (23.0%)	10 (31.3%)	.37
Transfusion volume (unit)	0.58 ± 0.91	1.28 ± 1.28	.01	0.46 ± 0.88	0.56 ± 0.91	.59
Length of hospital stays (days)	27.91 ± 7.76	29.94 ± 8.84	.27	25.96 ± 9.32	26.63 ± 13.93	.77

^*Chronic kidney disease.

^†Ferric derisomaltose.

^‡Postoperative day.

^§Hemoglobin.